Fundacion para la Innovacion en Biomedicina (FIBMED)
5
3
4
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Evaluation of the BMPR2-Activin Signaling Pathway in Group II Pulmonary Hypertension.
Role: collaborator
Non-Invasive Electrocardiographic Imaging for Personalized Arrhythmia Care in Congenital Heart Disease
Role: lead
Multitarget Pulse Field Ablation Guided by Endocardial and Non-invasive Atrial Driver Mapping (PFA+ADM) Pilot Study. Development of an Ablation Strategy to Improve the Efficacy of Long Standing Atrial Fibrillation Ablation in Patients With High Comorbidity Burden or Heart Failure
Role: lead
Radial Ablation for the Control of Persistent Atrial Fibrillation
Role: lead
Hybrid Characterization of Driver Sites During Atrial Fibrillation and Sinus Rhythm
Role: lead
All 5 trials loaded